{"product_id":"test-urinaire-drugdiag®-6t2-nouvelles-drogues-de-synthese","title":"6-Drug Urine Test Drugdiag® 6T2 - New Synthetic Drugs","description":"\u003cstyle\u003e\n\/* =========================================================\n   AMA Prévention — B-SAFE\n   Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n   Sans JS — prêt Shopify\n   ========================================================= *\/\n\n.ama-bsafe-2026 {\n  --ama-blue: #004C96;\n  --ama-blue-deep: #003B78;\n  --ama-blue-night: #00325f;\n  --ama-orange: #FE4B09;\n  --ama-text: #004C96;\n  --ama-muted: #667085;\n  --ama-border: #dbe6f2;\n  --ama-soft: #f6f9fd;\n  --ama-white: #ffffff;\n\n  width: 100%;\n  max-width: 1180px;\n  margin: 0 auto;\n  padding: 0;\n  font-family: inherit;\n  color: var(--ama-text);\n  background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n  box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n  min-width: 0;\n}\n\n.ama-bsafe-panel {\n  width: 100%;\n  position: relative;\n  overflow: hidden;\n  isolation: isolate;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 28px;\n  background:\n    radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n    radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n    linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n  box-shadow:\n    0 22px 55px rgba(0, 76, 150, 0.10),\n    inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n  width: 100%;\n  padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n  margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  margin-bottom: 14px;\n  padding: 7px 12px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 12px;\n  font-weight: 900;\n  letter-spacing: 0.04em;\n  text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n  margin: 0 0 16px;\n  color: var(--ama-blue);\n  font-size: clamp(30px, 4vw, 46px);\n  line-height: 1.08;\n  font-weight: 900;\n  letter-spacing: -0.045em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n  margin: 0 0 16px;\n  color: var(--ama-text);\n  font-size: clamp(16px, 1.4vw, 18px);\n  line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n  color: var(--ama-blue);\n  font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n  display: flex;\n  flex-wrap: wrap;\n  gap: 10px;\n  margin-top: 26px;\n  padding: 14px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: rgba(255, 255, 255, 0.72);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  flex: 1 1 230px;\n  padding: 10px 12px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  color: var(--ama-blue);\n  font-size: 14px;\n  font-weight: 850;\n  line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n  flex-shrink: 0;\n}\n\n\/* =========================================================\n   Accordéon principal\n   Fermé : bleu nuit\n   Ouvert : clair + contenu dans le même bloc\n   ========================================================= *\/\n\n.ama-bsafe-accordion {\n  width: 100%;\n  max-width: 920px;\n  margin: 0 auto;\n  display: grid;\n  gap: 12px;\n}\n\n.ama-bsafe-item {\n  border-radius: 24px;\n  overflow: hidden;\n  background:\n    linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n  border: 1px solid rgba(0, 76, 150, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.22),\n    inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n    0 16px 36px rgba(0, 76, 150, 0.17);\n  transition:\n    background 220ms ease,\n    box-shadow 220ms ease,\n    border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n  background:\n    radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n    linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n  border-color: rgba(0, 76, 150, 0.14);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.98),\n    0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n  position: relative;\n  min-height: 66px;\n  padding: 14px 58px 14px 18px;\n  display: flex;\n  align-items: center;\n  cursor: pointer;\n  list-style: none;\n  user-select: none;\n  -webkit-tap-highlight-color: transparent;\n  color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-item[open] summary {\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n  border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 16px;\n  top: 50%;\n  width: 36px;\n  height: 36px;\n  transform: translateY(-50%);\n  border-radius: 999px;\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  color: #ffffff;\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n  border: 1px solid rgba(255, 255, 255, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.30),\n    0 10px 22px rgba(0, 0, 0, 0.14);\n  font-size: 22px;\n  font-weight: 760;\n  line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n  content: \"−\";\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n  border-color: rgba(0, 76, 150, 0.10);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.96),\n    0 8px 18px rgba(0, 76, 150, 0.10);\n  font-size: 24px;\n  font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-item:not([open]):hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.26),\n      inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n      0 20px 44px rgba(0, 76, 150, 0.22);\n  }\n\n  .ama-bsafe-item[open]:hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.98),\n      0 18px 42px rgba(0, 76, 150, 0.13);\n  }\n}\n\n.ama-bsafe-acc-title {\n  display: block;\n  font-size: 16px;\n  line-height: 1.18;\n  font-weight: 800;\n  letter-spacing: -0.018em;\n  color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n  display: block;\n  margin-top: 3px;\n  font-size: 13px;\n  line-height: 1.24;\n  font-weight: 650;\n  letter-spacing: -0.01em;\n  color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n  color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n  padding: clamp(20px, 4vw, 34px);\n  background: transparent;\n  animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n  from {\n    opacity: 0;\n    transform: translateY(5px);\n  }\n\n  to {\n    opacity: 1;\n    transform: translateY(0);\n  }\n}\n\n\/* =========================================================\n   Contenu\n   ========================================================= *\/\n\n.ama-bsafe-content h2 {\n  margin: 0 0 18px;\n  color: var(--ama-blue);\n  font-size: clamp(24px, 3vw, 36px);\n  line-height: 1.10;\n  font-weight: 900;\n  letter-spacing: -0.04em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n  content: \"\";\n  display: block;\n  width: 78px;\n  height: 4px;\n  margin-top: 14px;\n  border-radius: 999px;\n  background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n  margin: 0 0 10px;\n  color: var(--ama-blue);\n  font-size: clamp(18px, 1.7vw, 23px);\n  line-height: 1.18;\n  font-weight: 900;\n  letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n  margin: 0 0 18px;\n  color: var(--ama-text);\n  font-size: 16px;\n  line-height: 1.72;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n  display: grid;\n  grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n  gap: 18px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-card {\n  position: relative;\n  min-height: 150px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 22px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow-wrap: break-word;\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n  margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-card:hover,\n  .ama-bsafe-substance-row:hover {\n    transform: translateY(-2px);\n    border-color: rgba(254, 75, 9, 0.32);\n    background: #ffffff;\n    box-shadow:\n      0 16px 34px rgba(0, 76, 150, 0.10),\n      inset 0 1px 0 rgba(255, 255, 255, 0.95);\n  }\n}\n\n.ama-bsafe-substance-list {\n  display: grid;\n  gap: 12px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n  width: 100%;\n  display: flex;\n  align-items: center;\n  flex-wrap: wrap;\n  gap: 12px 18px;\n  padding: 16px 18px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 130px;\n  width: 130px;\n  min-width: 130px;\n  max-width: 130px;\n  min-height: 38px;\n  padding: 7px 14px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 15px;\n  font-weight: 950;\n  letter-spacing: -0.01em;\n  text-align: center;\n}\n\n.ama-bsafe-substance-main {\n  flex: 1 1 420px;\n  min-width: min(100%, 320px);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 auto;\n  margin-left: auto;\n  min-height: 34px;\n  padding: 6px 12px;\n  border-radius: 999px;\n  background: rgba(254, 75, 9, 0.08);\n  color: var(--ama-orange);\n  font-size: 13px;\n  font-weight: 900;\n  white-space: nowrap;\n}\n\n.ama-bsafe-list {\n  list-style: none;\n  padding: 0;\n  margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n  position: relative;\n  padding: 15px 18px 15px 44px;\n  margin-bottom: 10px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.84);\n  box-shadow:\n    0 6px 18px rgba(0, 76, 150, 0.035),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.62;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n  content: \"\";\n  position: absolute;\n  left: 18px;\n  top: 22px;\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n  margin: 22px 0;\n  padding: 18px 20px;\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  border-radius: 18px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  color: var(--ama-muted);\n  font-size: 14px;\n  line-height: 1.62;\n  font-style: italic;\n  box-shadow:\n    0 8px 20px rgba(0, 76, 150, 0.04),\n    inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n  margin: 28px 0;\n  padding: 24px;\n  border-radius: 22px;\n  background:\n    radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n    linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  box-shadow:\n    0 16px 34px rgba(254, 75, 9, 0.22),\n    inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n  color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n  margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n  margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n  display: grid;\n  gap: 12px;\n  margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n  cursor: pointer;\n  padding: 18px 50px 18px 18px;\n  color: var(--ama-blue);\n  font-weight: 900;\n  line-height: 1.35;\n  list-style: none;\n  position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-faq summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 18px;\n  top: 50%;\n  transform: translateY(-50%);\n  color: var(--ama-orange);\n  font-size: 24px;\n  line-height: 1;\n  font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n  content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n  padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n  margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n  margin-top: 30px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 24px;\n  background:\n    radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n    linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 14px 34px rgba(0, 76, 150, 0.08),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n  margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  min-height: 46px;\n  padding: 12px 22px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  color: #ffffff !important;\n  font-weight: 900;\n  text-decoration: none;\n  box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n  margin-top: 30px;\n  padding-top: 22px;\n  border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n  margin: 0;\n  color: var(--ama-muted);\n  font-size: 13px;\n  line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n  max-width: 1180px;\n  margin: 32px auto 0;\n  padding: 24px;\n  border: 1px solid rgba(0, 76, 150, 0.18);\n  border-radius: 22px;\n  background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n  box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n  color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n  margin: 0 0 8px;\n  font-size: 13px;\n  letter-spacing: 0.08em;\n  text-transform: uppercase;\n  font-weight: 900;\n  color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n  margin: 0 0 12px;\n  color: #004c96;\n  font-size: clamp(22px, 2.4vw, 30px);\n  line-height: 1.15;\n  font-weight: 900;\n  letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n  margin: 0 0 10px;\n  line-height: 1.65;\n  color: #184b78;\n  font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n  margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n  .ama-bsafe-grid {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n  }\n\n  .ama-bsafe-substance-row {\n    display: grid;\n    grid-template-columns: 130px minmax(0, 1fr);\n    align-items: start;\n    gap: 10px 14px;\n  }\n\n  .ama-bsafe-substance-code {\n    grid-column: 1;\n    grid-row: 1;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 2;\n    grid-row: 1;\n    justify-self: start;\n    margin-left: 0;\n  }\n\n  .ama-bsafe-substance-main {\n    grid-column: 1 \/ -1;\n    grid-row: 2;\n    min-width: 0;\n    width: 100%;\n  }\n}\n\n@media (max-width: 640px) {\n  .ama-bsafe-panel {\n    border-radius: 22px;\n  }\n\n  .ama-bsafe-inner {\n    padding: 24px 14px;\n  }\n\n  .ama-bsafe-title {\n    font-size: clamp(28px, 8.4vw, 36px);\n    letter-spacing: -0.035em;\n  }\n\n  .ama-bsafe-summary-strip {\n    display: grid;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-summary-item {\n    border-radius: 16px;\n  }\n\n  .ama-bsafe-accordion {\n    gap: 10px;\n  }\n\n  .ama-bsafe-item {\n    border-radius: 20px;\n  }\n\n  .ama-bsafe-item summary {\n    min-height: 60px;\n    padding: 12px 52px 12px 15px;\n  }\n\n  .ama-bsafe-item summary::after {\n    right: 14px;\n    width: 32px;\n    height: 32px;\n    font-size: 20px;\n  }\n\n  .ama-bsafe-item[open] summary::after {\n    font-size: 22px;\n  }\n\n  .ama-bsafe-acc-title {\n    font-size: 15px;\n    line-height: 1.18;\n    letter-spacing: -0.014em;\n  }\n\n  .ama-bsafe-acc-sub {\n    font-size: 12.2px;\n    line-height: 1.22;\n  }\n\n  .ama-bsafe-content {\n    padding: 20px 15px;\n  }\n\n  .ama-bsafe-content h2 {\n    font-size: clamp(24px, 7vw, 30px);\n  }\n\n  .ama-bsafe-grid {\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-card {\n    padding: 20px;\n  }\n\n  .ama-bsafe-substance-row {\n    padding: 16px;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-substance-code {\n    width: fit-content;\n    min-width: 0;\n    max-width: 100%;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 1;\n    grid-row: auto;\n  }\n\n  .ama-bsafe-validation {\n    padding: 20px;\n    border-radius: 20px;\n  }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6T2 drogues festives\"\u003e\n  \u003cdiv class=\"ama-bsafe-panel\"\u003e\n    \u003cdiv class=\"ama-bsafe-inner\"\u003e\n      \u003cheader class=\"ama-bsafe-header\"\u003e\n              \u003cspan class=\"ama-bsafe-kicker\"\u003eUrine test for party drugs without cannabis\u003c\/span\u003e\n      \n              \u003ch2 class=\"ama-bsafe-title\"\u003e\n                Drugdiag® 6T2: urine test for ketamine, MDMA, 3-MMC, opiates, amphetamines, and methamphetamines\n              \u003c\/h2\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                The \u003cstrong\u003eDrugdiag® 6T2 urine test\u003c\/strong\u003e, developed by the \u003cstrong\u003eFrench laboratory Toda Pharma\u003c\/strong\u003e, targets the main \u003cstrong\u003eparty drugs\u003c\/strong\u003e, stimulants, dissociatives, and opiates currently most sought after, \u003cstrong\u003eexcluding cannabis\u003c\/strong\u003e.\n              \u003c\/p\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                It allows detection in a single step of \u003cstrong\u003eketamine (KET)\u003c\/strong\u003e, \u003cstrong\u003eMDMA \/ ecstasy\u003c\/strong\u003e, \u003cstrong\u003eopiates (MOP)\u003c\/strong\u003e, \u003cstrong\u003e3-MMC\u003c\/strong\u003e, \u003cstrong\u003eamphetamines (AMP)\u003c\/strong\u003e, and \u003cstrong\u003emethamphetamines (MET)\u003c\/strong\u003e.\n              \u003c\/p\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                This urine test meets the needs of \u003cstrong\u003eindividuals\u003c\/strong\u003e, \u003cstrong\u003ehealth professionals\u003c\/strong\u003e, \u003cstrong\u003eprevention organizations\u003c\/strong\u003e, \u003cstrong\u003ecompanies\u003c\/strong\u003e, and \u003cstrong\u003eactors in the festive scene\u003c\/strong\u003e wishing to quickly identify the main families of stimulant, synthetic, dissociative, and opiate substances.\n              \u003c\/p\u003e\n      \n              \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003e6 targeted families without cannabis\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eKET, MDMA, MOP, 3-MMC, AMP, MET\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003ePrevention, health, parties, and festivals\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n      \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eDetection\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 party drugs\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eDetected substances\u003c\/h2\u003e\n\n          \u003cp\u003e\n            The Drugdiag® 6T2 targets six families of substances particularly sought after in festive, professional, medical, or prevention contexts, with a specific focus excluding cannabis.\n          \u003c\/p\u003e\n\n          \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eKET\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eKetamine:\u003c\/strong\u003e ketamine, Special K, Ket, a dissociative substance that can strongly impair alertness.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA, ecstasy, taz, tata, molly, a stimulant and empathogen.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e morphine, heroin, opium, and related compounds.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003e3-MMC\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eSynthetic cathinone:\u003c\/strong\u003e 3-MMC, 3MMC, 3-M, a stimulant often associated with the party scene.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e speed, pep, amphetamines, and related stimulants.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e meth, crystal, crystal meth, ice, and related derivatives.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            The Drugdiag® 6T2 is especially suited for detecting the most commonly sought party drugs and stimulants: ketamine, ecstasy, 3-MMC, speed, crystal meth, and opiates. It does not target cannabis.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eUses\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePrevention, health, festive\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eWhy is this test particularly useful today?\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-bsafe-grid\"\u003e\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eFestive environment and polyconsumption\u003c\/h3\u003e\n              \u003cp\u003e\n                In the evening, at festivals, clubs, or in contexts of polyconsumption, substances in circulation can include ketamine, MDMA, 3-MMC, amphetamines, methamphetamines, and opiates. This test allows for a broader detection than a limited screening.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003ePrevention and risk understanding\u003c\/h3\u003e\n              \u003cp\u003e\n                In case of doubt, unusual behavior, distress, or suspected use, the Drugdiag® 6T2 helps better understand which substance family may be involved.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eHealthcare professionals\u003c\/h3\u003e\n              \u003cp\u003e\n                The test can help guide care, follow-up, or request biological confirmation when the clinical context requires it.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eEvent venues and field workers\u003c\/h3\u003e\n              \u003cp\u003e\n                It can be useful for prevention organizations, event organizers, associations, harm reduction teams, and actors facing poorly identified substances.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eKey features of the Drugdiag® 6T2\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eTargeted screening:\u003c\/strong\u003e detects main party drugs, stimulants, and opiates without including cannabis.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eWide coverage:\u003c\/strong\u003e ketamine, MDMA, opiates, 3-MMC, amphetamines, and methamphetamines.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eRisk reading:\u003c\/strong\u003e helps differentiate several very different substance families.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eQuick result:\u003c\/strong\u003e visual reading in a few minutes according to the manufacturer’s instructions.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFrench manufacturer:\u003c\/strong\u003e device designed by the Toda Pharma laboratory, the leader in rapid diagnostic testing.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eProfessional quality:\u003c\/strong\u003e CE marking, ISO 13485 quality environment, and batch traceability.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003ePrevention tool:\u003c\/strong\u003e useful for individuals, healthcare professionals, event venues, and field workers.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cdiv class=\"ama-bsafe-alert\"\u003e\n            \u003ch3\u003eWhy are these substances so concerning?\u003c\/h3\u003e\n            \u003cp\u003e\n              Ketamine, MDMA, 3-MMC, amphetamines, methamphetamines, and opiates can cause severe effects: agitation, overstimulation, hallucinations, disorientation, loss of control, deep sedation, respiratory depression, or severe distress depending on the substances and mixtures.\n            \u003c\/p\u003e\n            \u003cp\u003e\n              A rapid test can guide suspicion but never replaces medical care or laboratory toxicological analysis when the context requires it.\n            \u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eResults\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eReading and interpretation\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eReading and interpretation\u003c\/h2\u003e\n\n          \u003cp\u003e\n            The Drugdiag® 6T2 provides a preliminary analytical result. It allows for quick guidance on suspected exposure to certain families of party drugs, stimulants, dissociatives, or opiates.\n          \u003c\/p\u003e\n\n          \u003cdiv class=\"ama-inner-accordion\"\u003e\n            \u003cdetails open\u003e\n              \u003csummary\u003eNegative result\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  A negative result indicates that the targeted families were not detected above the test thresholds. This does not guarantee the absolute absence of any substance, especially if the molecule present is not part of the tested panel.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003ePositive result\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  A positive result indicates a reaction compatible with the presence of a targeted family: ketamine, MDMA, opiates, 3-MMC, amphetamines, or methamphetamines. In medical, professional, official, or disputed contexts, laboratory confirmation is recommended.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eInvalid result\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  An invalid result may be due to incorrect handling, insufficient sample volume, or failure to respect the reading time. In this case, the test should be redone with a new device.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eStreet names associated with targeted families\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eKET:\u003c\/strong\u003e ketamine, Special K, Ket.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMDMA:\u003c\/strong\u003e ecstasy, taz, tata, molly.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMOP:\u003c\/strong\u003e hero, heroin, opium, morphine.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003e3-MMC:\u003c\/strong\u003e 3-MMC, 3MMC, 3-M.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eAMP:\u003c\/strong\u003e speed, pep, amphetamines.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMET:\u003c\/strong\u003e meth, crystal, crystal meth, ice.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            Street names change quickly and never guarantee the actual composition of the consumed product. The same name can refer to different substances depending on the batch, region, or distribution channel.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eTechnique\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQuality and reliability\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eTechnical expertise\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-bsafe-grid\"\u003e\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eColloidal gold technology\u003c\/h3\u003e\n              \u003cp\u003e\n                The device uses competitive immunochromatography with colloidal gold-labeled antibodies, allowing clear, rapid reading suitable for professional use.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eGC\/MS reliability\u003c\/h3\u003e\n              \u003cp\u003e\n                The accuracy of this professional urine screening device has been compared to the laboratory reference method, gas chromatography coupled with mass spectrometry (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eQuality compliance\u003c\/h3\u003e\n              \u003cp\u003e\n                Designed by the French laboratory Toda Pharma, this \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is CE marked, complies with the ISO 13485 quality standard, and offers full batch traceability.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eMain features\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eTest type:\u003c\/strong\u003e urine test focused on party drugs, stimulants, dissociatives, and opiates.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eTargeted families:\u003c\/strong\u003e KET, MDMA, MOP, 3-MMC, AMP, MET.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFeature:\u003c\/strong\u003e specific panel without cannabis.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e rapid-read urine device.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eUse:\u003c\/strong\u003e prevention, health, event venues, field, companies, and responsible self-testing.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e French laboratory Toda Pharma, the number 1 in rapid diagnostic testing.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eQuality:\u003c\/strong\u003e in vitro diagnostic medical device with CE marking and ISO 13485.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003ch3\u003eNo cross-reactivity\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eCommon medications:\u003c\/strong\u003e aspirin, ibuprofen, paracetamol, amoxicillin, penicillin, dextromethorphan.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003ePhysiological and dietary substances:\u003c\/strong\u003e caffeine, cholesterol, hemoglobin, creatinine, vitamin C, uric acid.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            The test must be used according to the manufacturer’s instructions. In case of a positive, doubtful, or disputed result, confirmation by laboratory analysis is still recommended.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eFAQ\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFrequently Asked Questions\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-inner-accordion\"\u003e\n            \u003cdetails open\u003e\n              \u003csummary\u003eDoes the test detect ketamine?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Yes. The Drugdiag® 6T2 detects \u003cstrong\u003eketamine (KET)\u003c\/strong\u003e with a threshold of \u003cstrong\u003e1000 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eDoes the test detect 3-MMC?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Yes. It specifically targets \u003cstrong\u003e3-MMC\u003c\/strong\u003e with a detection threshold of \u003cstrong\u003e1000 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eDoes the test detect ecstasy?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Yes. It detects \u003cstrong\u003eMDMA\u003c\/strong\u003e, often called \u003cstrong\u003eecstasy\u003c\/strong\u003e, \u003cstrong\u003etaz\u003c\/strong\u003e, or \u003cstrong\u003emolly\u003c\/strong\u003e, with a threshold of \u003cstrong\u003e500 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eDoes the test detect speed and crystal meth?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Yes. It detects \u003cstrong\u003eamphetamines (AMP)\u003c\/strong\u003e and \u003cstrong\u003emethamphetamines (MET)\u003c\/strong\u003e, notably known as \u003cstrong\u003espeed\u003c\/strong\u003e, \u003cstrong\u003emeth\u003c\/strong\u003e, \u003cstrong\u003ecrystal meth\u003c\/strong\u003e, or \u003cstrong\u003eice\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eWhy does this test not include cannabis?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Because it is designed to specifically target other substance families: ketamine, ecstasy, opiates, 3-MMC, amphetamines, and methamphetamines. It is therefore relevant when the need concerns party drugs excluding cannabis.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eDoes a positive result have definitive value?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  No. A rapid test provides a preliminary analytical result. In any official, medical, judicial, administrative, disciplinary, or disputed context, confirmation by laboratory analytical method is recommended.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n          \u003c\/div\u003e\n\n          \u003cdiv class=\"ama-bsafe-cta\"\u003e\n            \u003cp\u003eNeed advice or a quote for a professional order?\u003c\/p\u003e\n            \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n              Request a quote\n            \u003c\/a\u003e\n          \u003c\/div\u003e\n\n          \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n            \u003cp\u003e\n              \u003cstrong\u003eLegal notice:\u003c\/strong\u003e This \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is intended for preventive, professional, or responsible personal use. It provides a preliminary analytical result and does not replace a laboratory toxicological analysis. In case of a positive, doubtful, disputed result or in official, medical, judicial, administrative, or disciplinary situations, confirmation by laboratory analytical method is recommended.\n            \u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unit","offer_id":56426436034884,"sku":null,"price":19.0,"currency_code":"USD","in_stock":true},{"title":"Pack of 5","offer_id":56426436067652,"sku":null,"price":94.0,"currency_code":"USD","in_stock":true},{"title":"Pack of 10","offer_id":56426436100420,"sku":null,"price":179.0,"currency_code":"USD","in_stock":true},{"title":"Pack of 25","offer_id":56426436133188,"sku":null,"price":399.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_NPS.png?v=1777893890","url":"https:\/\/ama-prevention.com\/products\/drugdiag-6t2-urine-test-new-synthetic-drugs","provider":"AMA Prévention ","version":"1.0","type":"link"}